Daily ideas

Pilgrim's Pride says China cleared 17 U.S. states from its avian influenza ban in Q2 2026, the first opening in three years; its own exports held flat.

On its 2026-07-30 call, Cigna named its AI high-cost-member model Personalized Care Coordination and first cited a 42% drop in avoidable inpatient stays.

First Watch retired its low-double-digit unit growth target for a flat 50 company-owned openings from 2027 after capex outran operating cash flow.

Grab's AIR shuttle in Singapore's Punggol has served over 9,000 riders since January, yet no commercial fare has been charged; management plans to start charging in Q4.

Demant reported the global hearing aid market grew 4% in value on 3% in units in H1 2026, about a point of ASP, and priced its new flagship above the last one.

Employers Holdings reported a 94% AI staff adoption rate on its 2026-07-30 call, and its CEO said the new excess workers' comp product was built with AI.

PGG Wrightson says New Zealand wool prices hit a decades high and nearly doubled in FY2026, with export volumes up and agency operating EBITDA 23% higher.

On its 2026-08-03 call, EverQuote said seven of its top 10 carriers use AI bidding product Smart Campaigns and revenue flowing through it rose over 100% year over year.

About 60% of Kornit's Q2 and first-half 2026 system sales went to traditional screen printers as retailers held inventory down high-single to low-double digits.

PicPay says a company-wide AI platform helped push its adjusted efficiency ratio to 44.8% and cancel a planned 10% hiring increase, though costs still grew 11.8% sequentially.

Data I/O (DAIO) and SEALSQ (LAES) say the EU Cyber Resilience Act's 11 September 2026 and 11 December 2027 deadlines turn per-device key injection into a condition of selling into the EU.

Liepin says AI product cash billings grew nearly 100% in 1H 2026 off an RMB 100 million base, lifting revenue with paid customers flat, but discloses no AI revenue.

Japan's conditional approval pathway set a ¥53.2 million reimbursed price for ReHeart, making MHLW the first regulator to price cardiac cell therapy.

Kura and Syndax each report about 40% of menin inhibitor use in physician-led combinations, moving the revenue variable to treatment duration rather than the label.

The draft KDIGO acute kidney injury guideline raises regional citrate to 1B and names nafamostat as a fallback, a protocol most US ICUs do not run today.

SPMC's FY2027 Q1 net investment income stayed below its common distributions partly because it raised model loss reserves on AI-affected software loans.

Denmark exempted the 0-30% LTV band from its 7% CRE systemic risk buffer, cutting sector buffer capital from DKK 11.6bn to about DKK 9bn in Q2 2026.

After UBS completed its Credit Suisse client migration, BCV's mortgage book grew just 2% in H1 2026 against a 4% target while pension cash moved in.

Erdene and Largo say buyers are approaching molybdenum and tungsten assets with no current study - one pre-PEA, one idle since 2012 - after China tightened export licensing.